ArticleAngiogenesis2016

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes.

Douglas A MacDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.